Akoya Biosciences Stock Cash And Equivalents
| AKYADelisted Stock | USD 1.29 0.00 0.00% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Akoya Biosciences' long-term financial health and intrinsic value.
Akoya |
Akoya Biosciences Company Cash And Equivalents Analysis
Akoya Biosciences' Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Akoya Biosciences Cash And Equivalents | 87.61 M |
Most of Akoya Biosciences' fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Akoya Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
CompetitionIn accordance with the recently published financial statements, Akoya Biosciences has 87.61 M in Cash And Equivalents. This is 89.33% lower than that of the Health Care Equipment & Supplies sector and 72.1% lower than that of the Health Care industry. The cash and equivalents for all United States stocks is 96.76% higher than that of the company.
Akoya Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Akoya Biosciences' direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Akoya Biosciences could also be used in its relative valuation, which is a method of valuing Akoya Biosciences by comparing valuation metrics of similar companies.Akoya Biosciences is currently under evaluation in cash and equivalents category among its peers.
Akoya Fundamentals
| Return On Equity | -3.54 | ||||
| Return On Asset | -0.17 | ||||
| Profit Margin | (0.59) % | ||||
| Operating Margin | (0.80) % | ||||
| Current Valuation | 120.62 M | ||||
| Shares Outstanding | 49.95 M | ||||
| Shares Owned By Insiders | 72.58 % | ||||
| Shares Owned By Institutions | 69.79 % | ||||
| Number Of Shares Shorted | 2.64 M | ||||
| Price To Book | 6.45 X | ||||
| Price To Sales | 0.81 X | ||||
| Revenue | 81.67 M | ||||
| Gross Profit | 49.37 M | ||||
| EBITDA | (37.14 M) | ||||
| Net Income | (55.37 M) | ||||
| Cash And Equivalents | 87.61 M | ||||
| Cash Per Share | 2.31 X | ||||
| Total Debt | 84.15 M | ||||
| Debt To Equity | 0.61 % | ||||
| Current Ratio | 3.55 X | ||||
| Book Value Per Share | (0.12) X | ||||
| Cash Flow From Operations | (44.1 M) | ||||
| Short Ratio | 2.64 X | ||||
| Earnings Per Share | (0.96) X | ||||
| Target Price | 1.51 | ||||
| Number Of Employees | 205 | ||||
| Beta | 1.35 | ||||
| Market Capitalization | 64.44 M | ||||
| Total Asset | 125 M | ||||
| Retained Earnings | (285.44 M) | ||||
| Working Capital | 47.29 M | ||||
| Net Asset | 125 M |
About Akoya Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Akoya Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Akoya Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Akoya Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in Akoya Stock
If you are still planning to invest in Akoya Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Akoya Biosciences' history and understand the potential risks before investing.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Global Correlations Find global opportunities by holding instruments from different markets |